Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
276studies shown
Showing 253-264 of 276
Drug study icon
CompletedNCT00763971

Safety study of Lisdexamfetamine Dimesylate (LDX) in ADHD

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.

In Belgium
ADHDDrugA study involving a medication or substance.From 6 Years to 17 Years
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT00259870

SB-773812 Administered In Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Belgium, Costa Rica, ...
Sponsor
GlaxoSmithKline
Condition
Schizophrenia
Behavioral study icon
Active Not RecruitingNCT07177547

Screening and Referral Practices for depression

This study is active but not recruiting in Belgium. It is testing screening and Referral Practices for depression.

Remote / online
Depression, AnxietyBehavioralOver 18 Years
Countries
Belgium
Sponsor
Ana Catarina Navarro Ramalho
Condition
Depression, Anxiety
Behavioral study icon
CompletedNCT04723719

Sleep IntervEntion as Symptom Treatment for ADHD

This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

In Belgium
ADHDBehavioralFrom 13 Years to 17 Years
Countries
Belgium
Sponsor
Universitaire Ziekenhuizen KU Leuven
Condition
ADHD
Other study type icon
CompletedEUCTR 2004-004461-15

SOLIAN solution in the acute setting

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
SchizophreniaOther
Countries
Belgium
Sponsor
SANOFI-SYNTHELABO
Condition
Schizophrenia
Other study type icon
CompletedNCT01062607

the Clinical Management of Bipolar Disease

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
BipolarityOtherOver 18 Years
Countries
France, Belgium, Austria, ...
Sponsor
AstraZeneca
Condition
Bipolarity
Drug study icon
CompletedNCT03185819

3 Fixed Doses of Intranasal Esketamine for depression

This study is completed in the United States, in France, in Belgium, .... It is testing 3 Fixed Doses of Intranasal Esketamine for depression.

In Belgium
Depression, SuicidalityDrugFrom 9 Years to 17 Years
Countries
United States, France, Belgium, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.